1. Mast cell stabilization improves cardiac contractile function following hemorrhagic shock and resuscitation.
- Author
-
Santone, David J., Shahani, Rohan, Rubin, Barry B., Romaschin, Alex D., and Lindsay, Thomas F.
- Subjects
- *
MAST cells , *CARDIAC contraction , *HEMORRHAGIC shock , *RESUSCITATION , *LABORATORY rats , *REPERFUSION - Abstract
Hemorrhagic shock (HS) is associated with cardiac contractile dysfunction. Mast cell (MC) degranulation is hypothesized to mediate the cardiodepressant effect. Cardiac function was assessed after HS and resuscitation (HS/R) with the administration of the MC stabilizers to prevent MC degranulation. Anesthetized male Sprague-Dawley rats were randomized to sham-operated control or HS/R groups and underwent 60 min of HS followed by 2 h of resuscitated reperfusion. Animals in the HS/R groups were randomized to receive cromolyn (5 mg/kg), ketotifen (1 mg/kg), or saline 15 min before shock. Hearts were excised following HS or 2 h of reperfusion, and function was assessed on a Langendorff apparatus. A second group of randomized animals had serial blood samples taken to assess MC degranulation by quantifying levels of serum 3-hexosaminidase. Hearts were excised at 0 min (before HS) and following 60 min of US (before resuscitation) for a histological evaluation of MC density and degranulation. In vivo MC stabilization using ketotifen and cromolyn improved cardiac peak systolic pressure (P < 0.05), contractility (P < 0.05), and relaxation (P < 0.05) compared with that of HS controls. Serum β-hexosaminidase increased during HS/R and was inhibited by MC stabilization (P < 0.05). Degranulation was inhibited when assessed by histochemistry and immune fluorescence. The inhibition of MC degranulation can significantly improve cardiac function following HS/R. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF